Robin Stan, MD
Cardiology · Inglewood, CANPI 1912903048
Payments from drug & device makers
Across 470 payments — averaging $102.38 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Amgen$40K
- Novartis$2K
- Merck$665
- Pfizer$642
- Boehringer Ingelheim$570
- Novo Nordisk$550
- plus $3K from 28 others
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Amgen | 24 | $40,029 |
| Novartis | 146 | $2,194 |
| Merck | 28 | $665 |
| Pfizer | 41 | $642 |
| Boehringer Ingelheim | 28 | $570 |
| Novo Nordisk | 25 | $550 |
| AstraZeneca | 28 | $502 |
| Johnson & Johnson | 25 | $419 |
| Bayer | 25 | $397 |
| Abbott | 9 | $281 |
| E.r. Squibb & Sons, L.L.C. | 15 | $244 |
| Esperion Therapeutics, Inc. | 16 | $237 |
| Alnylam Pharmaceuticals Inc. | 7 | $174 |
| Scpharmaceuticals Inc. | 8 | $173 |
| Akcea Therapeutics, Inc. | 5 | $167 |
| Kestra Medical Technology Services, Inc. | 3 | $86 |
| Gilead | 4 | $80 |
| Regeneron Healthcare Solutions, Inc. | 3 | $79 |
| Bridgebio Pharma, Inc. | 3 | $76 |
| Kiniksa Pharmaceuticals, Ltd. | 3 | $70 |
| Boston Scientific | 4 | $57 |
| Sanofi-aventis U.S. LLC | 3 | $53 |
| Astellas Pharma US Inc | 3 | $52 |
| Edwards Lifesciences | 2 | $47 |
| Actelion Pharmaceuticals US, Inc. | 2 | $40 |
| Impulse Dynamics (USA) Inc. | 1 | $39 |
| Liquidia Technologies, Inc. | 1 | $31 |
| Heartflow, Inc. | 1 | $29 |
| Medtronic(2 entities) | 2 | $29 |
| Irhythm Technologies, Inc. | 1 | $24 |
| Vifor Pharma, Inc. | 1 | $24 |
| Preventice Services, LLC | 1 | $22 |
| GSK | 1 | $21 |
| Kowa Pharmaceuticals America, Inc. | 1 | $12 |
How this compares
$48,117 in reported general payments places this provider in the 90th percentile of 156 cardiology providers in California.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other cardiology in Inglewood
- Jack FarahiInglewood$10K
- Vernon HattoriInglewood$7K
- Norman LeporBeverly Hills$7.1M
- Sanjay KaulLos Angeles$1.1M
- Mahmoud Eslami-FarsaniSanta Ana$410K
- Anil ShahSanta Ana$372K
- Ramtin AgahMountain View$361K
- David LangeSan Francisco$221K
- Jamshid MaddahiLos Angeles$147K
- Harpreet SinghFountain Valley$57K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.